COG 133 is a fragment of Apolipoprotein E (APOE) peptide. COG 133 competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 is also a nAChR antagonist with an IC50 of 445 nM.
体外研究
COG 133 (1 mg/kg; intratracheal administration; every other day; for 4 weeks) treatment impairs the resolution of pulmonary fibrosis in mice.
Animal Model:
Male C57BL/6 mice (6-week-old) instilled with Bleomycin
Dosage:
1 mg/kg
Administration:
Intratracheal administration; every other day; for 4 weeks
Result:
Did blunt the resolution of lung fibrosis.
分子式
C97H181N37O19
分子量
2169.71302
CAS号
514200-66-9
运输条件
Room temperature in continental US; may vary elsewhere.